3D Medicines (Beijing) Co., Ltd.;Jiangsu Alphamab Biopharmaceuticals Co., Ltd.
发明人:
Xu, Ting,Dong, Yanrong,Wang, Pilin,Chen, Ting
申请号:
AU2016302951
公开号:
AU2016302951B2
申请日:
2016.08.01
申请国别(地区):
AU
年份:
2019
代理人:
摘要:
The present invention relates to the biomedical field, and provides a single domain antibody for programmed death-ligand (PD-L1) and a derived protein thereof. The present invention also provides a use of a PD-L1 binding molecule in treating and/or preventing and diagnosing a PD-L1 related disease, such as tumor.